| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/04/2009 | CN100457090C Milled particles |
| 02/04/2009 | CN100457089C Solid liposome nanoparticles of arenobufagin and preparation method thereof |
| 02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
| 02/04/2009 | CN100457087C Stable pharmaceutical solution formulation for pressurized metered dose inhalers |
| 02/04/2009 | CN100457086C Aseptic medicine composition |
| 02/04/2009 | CN100457085C Polyglycol nano preparation coated with Maka, or Kava, or gingerroot, or ginseng oil |
| 02/04/2009 | CN100457084C Nanometer silver type external use antibiotic gel for female external use and its preparation method |
| 02/04/2009 | CN100457078C Cosmetics |
| 02/04/2009 | CN100457064C Cutaneous drug delivery systems |
| 02/03/2009 | US7485659 Anticancer compositions, and methods of making and using the same |
| 02/03/2009 | US7485656 Fluconazole, a compound selected from a group consisting of fatty acid, fatty alcohol, higher fatty acid ester and lower alcohol and a base; favorable absorption and delivery through the human skin; low skin stimulation; stability; spreading |
| 02/03/2009 | US7485642 Administering levosimendan or a salt thereof |
| 02/03/2009 | US7485617 Osteoinductive materials |
| 02/03/2009 | US7485609 Personal cleansing article made of a capsule and a liquid cleansing composition contained within the capsule; capsule has a trigger such that upon occurrence of a specific event, the capsule releases the liquid; convenient to transport |
| 02/03/2009 | US7485326 Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin |
| 02/03/2009 | US7485323 Blend of 90-95% of a proteolytic hydrolized gelatin having an average primary amine content of 1.0x10-3 to 1.0x10-2 mu mol of primary amine per mu g of hydrolysate and 5-10% of gelatin; average viscosity of 10 to 15 cP; improved crosslinking and dissolution properties. |
| 02/03/2009 | US7485322 Modified release pharmaceutical composition |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485320 Liposome for incorporating large amounts of hydrophobic substances |
| 02/03/2009 | US7485319 Doxycycline metal complex in a solid dosage form |
| 02/03/2009 | US7485318 Biodegradable carrier and method for preparation thereof |
| 02/03/2009 | US7485317 Thermo-reversible polymer for intralumenal implant |
| 02/03/2009 | US7485294 Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2455208C Method of encapsulating an active substance |
| 02/03/2009 | CA2412055C Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same |
| 02/03/2009 | CA2395881C Inhalation particles |
| 02/03/2009 | CA2382902C Rapidly decomposing chitosan-based pellets |
| 02/03/2009 | CA2361377C Novel mucosal delivery system |
| 02/03/2009 | CA2341397C Immediate release tablet |
| 02/03/2009 | CA2316224C Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution |
| 02/03/2009 | CA2275321C Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation |
| 02/03/2009 | CA2226657C Improvements in and relating to powders for use in dry powder inhalers |
| 02/01/2009 | CA2595485A1 Liposomal compositions for parenteral delivery of statins |
| 01/29/2009 | WO2009015397A1 Methods for imaging using improved nanoparticulate contrast agents |
| 01/29/2009 | WO2009015345A1 Pharmaceutical compositions comprising fc fusion proteins |
| 01/29/2009 | WO2009015336A2 Controlled release interferon drug products and treatment of hcv infection using same |
| 01/29/2009 | WO2009015279A2 Agents and methods for inhibition of airway hyperresponsiveness |
| 01/29/2009 | WO2009015112A2 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 01/29/2009 | WO2009014762A1 Central administration of stable formulations of therapeutic agents for cns conditions |
| 01/29/2009 | WO2009014549A1 Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 01/29/2009 | WO2009014534A1 Formulations of nonopioid and confined opioid analgesics |
| 01/29/2009 | WO2009014533A1 Drug formulations having inert sealed cores |
| 01/29/2009 | WO2009014510A1 Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/29/2009 | WO2009014452A1 Omega-3 fatty acid fortified composition |
| 01/29/2009 | WO2009014441A2 Microparticles comprising pcl and uses thereof |
| 01/29/2009 | WO2009014372A2 Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof |
| 01/29/2009 | WO2009014347A2 Stabilized antioxidant-containing particles, process for preparing the same, and composition comprising the same |
| 01/29/2009 | WO2009013864A1 Vesicle composition and external preparation for skin |
| 01/29/2009 | WO2009013770A1 Derivatised polysaccharide material for the transdermal administration of drugs |
| 01/29/2009 | WO2009013594A2 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 01/29/2009 | WO2009013552A1 Controlled release pharmaceutical composition of tolperison hydrochloride |
| 01/29/2009 | WO2009013466A1 Preparation of fine particles |
| 01/29/2009 | WO2009013435A2 Preservative-free prostaglandin-based ophthalmic solution |
| 01/29/2009 | WO2009013356A2 Anti-hiv tablet formulations comprising darunavir |
| 01/29/2009 | WO2009013331A1 Topical antibiotic composition for the prevention of lyme disease |
| 01/29/2009 | WO2009013306A1 Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 01/29/2009 | WO2009013261A2 Derivatised polysaccharide material for the topic antibacterial activity |
| 01/29/2009 | WO2009013244A1 Novel medicament in powder form comprising tiotropium and salmeterol, and lactose as excipient |
| 01/29/2009 | WO2009013237A2 Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof |
| 01/29/2009 | WO2009013213A2 Method for charging an aerosol canister with a propellant drug formulation |
| 01/29/2009 | WO2009012987A1 Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof |
| 01/29/2009 | WO2009012908A2 Medicament for transdermal use on animals |
| 01/29/2009 | WO2009012791A1 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof |
| 01/29/2009 | WO2009012718A1 A composite emulsifier, an emulsion prepared from it and the preparation method thereof |
| 01/29/2009 | WO2009012601A1 Antigen-adjuvant compositions and methods |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008149215A3 Method for the preparation of solid lipid micro and nanoparticles |
| 01/29/2009 | WO2008149201A3 Stable pharmaceutical composition |
| 01/29/2009 | WO2008149177A3 Marine lipid compositions and uses thereof |
| 01/29/2009 | WO2008148212A3 High-amylose sodium carboxymethyl starch sustained release excipient and process for preparing the same |
| 01/29/2009 | WO2008145750A3 Method for coating surfaces with micro- and nanoparticles with the aid of plasma methods |
| 01/29/2009 | WO2008142627A3 Multilayered modified release formulation comprising amoxicillin and clavulanate |
| 01/29/2009 | WO2008120207A3 Compositions for nasal delivery |
| 01/29/2009 | WO2008120156A3 System and method for pill communication and control |
| 01/29/2009 | WO2008120131A3 Pharmaceutical compositions of diclofenac and misoprostol |
| 01/29/2009 | WO2008114089A3 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 01/29/2009 | WO2008104996A4 Water dispersible pharmaceutical formulation and process for preparing the same |
| 01/29/2009 | WO2008101469A3 Pharmaceutical preparation for treating metastases |
| 01/29/2009 | WO2008087034A3 Cyclodextrin formulations |
| 01/29/2009 | WO2008076333A9 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 01/29/2009 | WO2008075207A3 Anti-infection augmentation foamable compositions and kit and uses thereof |
| 01/29/2009 | WO2008075204A3 Lipoic acid derivatives |
| 01/29/2009 | WO2008062470A3 Stabilized controlled release dosage form of gliclazide |
| 01/29/2009 | WO2008035376A4 A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof |
| 01/29/2009 | WO2008035364A3 Process for the preparation of micronized valsartan |
| 01/29/2009 | WO2008023016A3 Galenic formulations of aliskiren |
| 01/29/2009 | WO2008004992A3 Transdermal formulations containing hepatitis c virus immunogens and an ethoxylated oil |
| 01/29/2009 | US20090030404 Containment device with multi-layer reservoir cap structure |
| 01/29/2009 | US20090030297 Implantable sensor method and system |
| 01/29/2009 | US20090030183 Interferon Beta-Like Molecules |
| 01/29/2009 | US20090030117 comprises alginates; anticancer agents; therapeutic vascular occlusions (embolizations) |
| 01/29/2009 | US20090029911 Liquid Human Growth Hormone Formulation Containing Polyethylene Glycol |
| 01/29/2009 | US20090029361 Growth differentiation factor-7 |
| 01/29/2009 | US20090029170 Extrusion |
| 01/29/2009 | US20090028957 Implantable Tissue-Reactive Biomaterial Compositions and Systems, and Methods of Us Thereof |
| 01/29/2009 | US20090028956 Polypeptide microparticles |
| 01/29/2009 | US20090028955 Ophthalmic emulsions containing an immunosuppressive agent |
| 01/29/2009 | US20090028954 Precursor for the preparation of a pasty bone replacement material by admixture of a liquid |
| 01/29/2009 | US20090028953 Method of treatment using microparticulate biomaterial composition |